Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
50
NCT00041795
Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2002
Completion: Not specified